Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Clinical Pharmacology
|
January 18, 2008
Communicating with the FDA: the "third rail" of a new model for drug development
Donald R Stanski, John J Orloff
Clinical Pharmacology and Therapeutics
|
April 14, 2021
The Titration Paradox Turns Pharmacology Upside Down
Steven L Shafer, Donald R Stanski
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2005
Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development
Donald R Stanski, Malcolm Rowland, Lewis B Sheiner
Lancet (London, England)
|
September 27, 2005
Inadequate anaesthesia in lethal injection for execution
Mark J S Heath, Donald R Stanski, Derrick J Pounder
Microbiology Spectrum
|
April 12, 2022
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19
Yuri Kosinsky, Kirill Peskov, Donald R Stanski, et al.
Physiological Reports
|
March 1, 2018
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics
Sergey Aksenov, Carl C Peck, Ulf G Eriksson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 27, 2014
Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylation
Nelleke Snelder, Bart A Ploeger, Olivier Luttringer, et al.
Respiratory Research
|
April 27, 2011
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
Didier Renard, Michael Looby, Benjamin Kramer, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Fostering culture and optimizing organizational structure for implementing model-based drug development
Liping Zhang, Sandra R Allerheiligen, Richard L Lalonde, et al.
Contemporary Clinical Trials
|
December 1, 2005
Enriched analgesic efficacy studies: an assessment by clinical trial simulation
Hendrikus J M Lemmens, D Russell Wada, Catherine Munera, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Clinical Pharmacology
|
January 18, 2008
Communicating with the FDA: the "third rail" of a new model for drug development
Donald R Stanski, John J Orloff
Clinical Pharmacology and Therapeutics
|
April 14, 2021
The Titration Paradox Turns Pharmacology Upside Down
Steven L Shafer, Donald R Stanski
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2005
Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development
Donald R Stanski, Malcolm Rowland, Lewis B Sheiner
Lancet (London, England)
|
September 27, 2005
Inadequate anaesthesia in lethal injection for execution
Mark J S Heath, Donald R Stanski, Derrick J Pounder
Microbiology Spectrum
|
April 12, 2022
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19
Yuri Kosinsky, Kirill Peskov, Donald R Stanski, et al.
Physiological Reports
|
March 1, 2018
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics
Sergey Aksenov, Carl C Peck, Ulf G Eriksson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 27, 2014
Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylation
Nelleke Snelder, Bart A Ploeger, Olivier Luttringer, et al.
Respiratory Research
|
April 27, 2011
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
Didier Renard, Michael Looby, Benjamin Kramer, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Fostering culture and optimizing organizational structure for implementing model-based drug development
Liping Zhang, Sandra R Allerheiligen, Richard L Lalonde, et al.
Contemporary Clinical Trials
|
December 1, 2005
Enriched analgesic efficacy studies: an assessment by clinical trial simulation
Hendrikus J M Lemmens, D Russell Wada, Catherine Munera, et al.
Page
of 2